Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome (multiple letter)

Journal of Infectious Diseases

Volumn 185, Issue 9, 2002, Pages 1376-1377

  Frater, John ^a   Dunn, David ^a   Weber, Jonathan N ^a   McClure, Myra O ^a   Perno, Carlo Federico ^a   Cozzi Lepri, Alessandro ^a   Balotta, Claudia ^a   D'Arminio Monforte, Antonella ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; PROTEINASE INHIBITOR; VIRUS ENZYME;

AFRICA; ANTIBIOTIC RESISTANCE; CODON; DNA POLYMORPHISM; DRUG EFFICACY; DRUG SENSITIVITY; ETHNOLOGY; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; MUTATION; TREATMENT OUTCOME;

EID: 0036568986     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340127     Document Type: Letter

References (0)